| Q33415432 | A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding |
| Q33496431 | Acute airway obstruction by laryngeal haematomas in acute immune thrombocytopenic purpura |
| Q42581063 | Cerebral infarction in idiopathic thrombocytopenic purpura: a case report |
| Q33441061 | Clinical updates in adult immune thrombocytopenia |
| Q33422858 | Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia |
| Q26779408 | Current Management of Primary Immune Thrombocytopenia |
| Q33371298 | Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure |
| Q33439371 | Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia |
| Q90602246 | Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018 |
| Q26865062 | Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography |
| Q33349867 | Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol |
| Q33420128 | Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRAN |
| Q26830918 | Immune thrombocytopenia |
| Q33415633 | Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics |
| Q53613284 | Laparoscopic splenectomy in the elderly: a morbid procedure? |
| Q60304458 | Life-threating outcomes after dental implantation in patient with idiopathic thrombocytopenic purpura: a case report and review of literature |
| Q33392610 | Long-term management of chronic immune thrombocytopenic purpura in adults |
| Q33393057 | Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy |
| Q33390001 | Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle |
| Q89777610 | Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry |
| Q33425502 | Presence of Essential Hypertension or Diabetes Mellitus Is a Predictor of Intracranial Bleeding in Elderly Patients: A Study of 108 Patients with Isolated Thrombocytopenia from a Single Reference Center |
| Q91992501 | Proposal of treatment algorithm for immune thromocytopenia in adult patients of a hematology service at a referral center in Northeastern Brazil |
| Q33365386 | Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura |
| Q53394126 | Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. |
| Q93487523 | Romiplostim (Nplate), a Treatment Option for Immune (Idiopathic) Thrombocytopenic Purpura |
| Q26826853 | Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review |
| Q99630718 | Temporal Trends of Intracranial Hemorrhage Among Immune Thrombocytopenia Hospitalizations in the United States |
| Q33496447 | The thrombocytopenic purpuras. Recognition and management |
| Q41823076 | Unusual presentation of chronic idiopathic thrombocytopenic purpura. |